Literature DB >> 3768255

The effect of glucose on acetylation status.

D Suhardjono, J Boutagy, G M Shenfield.   

Abstract

Forty-nine healthy volunteers (47 male, 2 female) had their sulphadimidine acetylator status determined on a control day and on a second occasion when they were given an oral glucose load. They were classified as fast and slow acetylators using the standard urine method and as fast, slow and intermediate acetylators using calculated metabolic and total body clearances. Twenty-seven (55%) were slow acetylators and this proportion was not altered by glucose loading either with or before sulphadimidine ingestion. On the control day, five (10%) were fast and 17 (35%) were intermediate acetylators but these sub-groups were not clearly distinguishable from each other when glucose was given. The glucose load did not cause any individual to change from slow to fast categories. Two type 2 (insulin independent) diabetics also showed no difference in acetylator status when studied with widely different blood glucose concentrations. We conclude that glucose can induce minor increases in sulphadimidine clearance but is unlikely to alter phenotypic acetylation status. Previous observations of an increased incidence of fast acetylators in diabetics may therefore indicate a genetic marker.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3768255      PMCID: PMC1401158          DOI: 10.1111/j.1365-2125.1986.tb02909.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  19 in total

1.  Acetylator phenotype in diabetic neuropathy.

Authors:  E H McLaren; A C Burden; P J Moorhead
Journal:  Br Med J       Date:  1977-07-30

2.  Glycosylated haemoglobin. Part I: Measurement and clinical interpretation.

Authors:  J P Ashby; A C Deacon; B M Frier
Journal:  Diabet Med       Date:  1985-03       Impact factor: 4.359

Review 3.  Disease and acetylation polymorphism.

Authors:  P K Lunde; K Frislid; V Hansteen
Journal:  Clin Pharmacokinet       Date:  1977 May-Jun       Impact factor: 6.447

4.  Simplified method for determining acetylator phenotype.

Authors:  H Schröder
Journal:  Br Med J       Date:  1972-08-26

5.  A simple pharmacokinetic method for separating the three acetylation phenotypes: a preliminary report.

Authors:  E J Lee; L K Lee
Journal:  Br J Clin Pharmacol       Date:  1982-03       Impact factor: 4.335

6.  Acetylator phenotypes and type I (insulin-dependent) diabetics with microvascular disease.

Authors:  H J Bodansky; P L Drury; A G Cudworth; D A Evans
Journal:  Diabetes       Date:  1981-11       Impact factor: 9.461

7.  Screening methods using sulfamethazine for determining acetylator phenotype.

Authors:  P du Souich; A J McLean; K Stoeckel; D Ohlendorf; M Gibaldi
Journal:  Clin Pharmacol Ther       Date:  1979-12       Impact factor: 6.875

8.  Diabetic dimorphism according to acetylator status.

Authors:  A W Burrows; T D Hockaday; J I Mann; J G Taylor
Journal:  Br Med J       Date:  1978-01-28

9.  Ethanol-induced increase in procainamide acetylation in man.

Authors:  H Olsen; J Mørland
Journal:  Br J Clin Pharmacol       Date:  1982-02       Impact factor: 4.335

10.  Ethanol-induced increase in drug acetylation in man and isolated rat liver cells.

Authors:  H Olsen; J Mørland
Journal:  Br Med J       Date:  1978-11-04
View more
  1 in total

1.  Acetylator phenotypes of Jordanian diabetics.

Authors:  Y Irshaid; H al-Hadidi; M Abuirjeie; A Latif; O Sartawi; N Rawashdeh
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.